november AG

euro adhoc: november AG
Liquidity Problems/Over-Indebtedness
IBL Hamburg AG files for insolvency

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@

20.12.2007

Erlangen, 20 December 2007. The Hamburg based IBL Gesellschaft für Immunchemie und Immunbiologie mbH, a 100% subsidiary of the Erlangen based development and holding company november AG (ISIN DE000A0S9N72) has filed for insolvency today, 20 December 2007, with the local court of Hamburg because of illiquidity and on-balance sheet over-indebtedness. This is because the ongoing negotiations with different banks relating to different loans could not be concluded in time before the expiry of the insolvency deadline.

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: november AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Marcus Weichert
november AG - Public Relations/Investor Relations
Ulrich-Schalk-Str. 3, D-91056 Erlangen
Tel.: +49 (0)9131 750 88 868
e-mail: weichert@november.de, www.november.de

Branche: Biotechnology
ISIN:      DE000A0S9N72
WKN:        A0S9N7
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse Hannover / free trade
              Börse München / free trade



Weitere Meldungen: november AG

Das könnte Sie auch interessieren: